Overview

Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery

Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of aprotinin as compared to placebo, in reducing the need for blood transfusion in adult subjects undergoing elective spinal fusion surgery involving 3 to 7 vertebral levels with instrumentation
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Aprotinin